Rivian Shorts Ease but Score Stays Bearish Ahead of Wednesday Print
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Rivian sits in the middle of its EV peer group on short positioning, less crowded than FFAI but carrying more bearish weight than TSLA, with 13.6% of its free float short as of Monday's close.
That 13.6% reading represents a meaningful drop from the recent peak. Short interest fell roughly 4.7% on Monday alone, pulling the total down from around 174 million shares to 166 million. The decline follows a sharp build-up through early October, when the position jumped from about 155 million shares to a 30-day high near 174 million. Even after the pullback, the one-month change remains positive at 1.7%, so the net result of October is more shorts, not fewer. Borrowing costs have eased alongside: the cost to borrow has dropped to 0.45%, its lowest in the 30-day window, down 15% on the week. Availability, at 153%, means roughly 1.5 shares remain available to borrow for every one already lent out, tighter than the 228% reading seen in mid-September but nowhere near stressed. The ORTEX short score of 72.5 places Rivian in the bottom 6th percentile of the universe, a reading that has been essentially static for the past ten sessions. Peer comparison puts the picture in context: XPEV and NIO are both down around 4% to 6% on the week, close to Rivian's own 4.9% decline, while TSLA diverged sharply, rising 9% over the same period, a gap that highlights how company-specific rather than sector-wide the Rivian pressure has been.
The insider register adds a point of contrast to the short positioning. Four directors received equity grants on October 20, routine compensation, but the same month saw the Chief Administrative Officer sell 15,000 shares under a pre-arranged 10b5-1 plan, his second such sale since September. The CFO also ran two plan-driven sales in August. All three executives were selling into a stock that has now lost nearly a quarter of its value in a month. Planned sales carry far less signal than discretionary ones, but the net 90-day insider flow of negative 51,000 shares, worth roughly $788,000 sold, leaves no open-market buying on the ledger to balance against.
Analysts remain constructive in aggregate, with a consensus buy rating and a mean price target of $19, implying roughly 61% upside from the current $11.82. The most recent move came from Citigroup in mid-September, initiating coverage at Neutral with an $18 target. Morgan Stanley continues to hold an Underweight rating, most recently with a $14 target, making it the most visible dissenter. The bull case rests on the R2 launch broadening the addressable market, the Volkswagen joint-venture software work providing a secondary revenue stream, and the Uber robotaxi partnership providing long-term optionality. The bear case centers on execution risk around the R2 ramp and the concentration of revenue in a narrow product line that must sustain high fixed costs while the company burns cash.
Wednesday's print will test whether Q3 delivery volumes and any updated R2 timeline guidance are enough to close the gap between a $19 consensus target and a stock trading nearly 40% below it.
Stocks in this article
See the live data behind this article on ORTEX.
Open RIVN on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 04:44
- Data as of
- 28 Oct 2026, 04:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.